Patten Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Patten Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,000	Closed	-$44.3K	–	634
2016 Q3	$44.3K	Buy	1,000 +999	+99,900%	+$52.1K	0.02%	331
2016 Q2	$50	Hold	1	–	–	﹤0.01%	637
2016 Q1	$53	Hold	1	–	–	﹤0.01%	671
2015 Q4	$65	Hold	1	–	–	﹤0.01%	697
2015 Q3	$56	Hold	1	–	–	﹤0.01%	598
2015 Q2	$59	Buy	+1	New	+$62	﹤0.01%	595

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Patten Group's TEVA Position: Q4 2016 in Review

Patten Group sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2016, closing a stake of 1,000 shares — an estimated $44.3K sold.

Patten Group first reported a position in TEVA in Q2 2015 and held it in 6 quarters. The position peaked at $44.3K in Q3 2016. 739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Patten Group reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2016 after selling out during the quarter.
Patten Group sold 1,000 Teva Pharmaceutical Industries Limited shares in Q4 2016, an estimated $44.3K.
Patten Group first reported a position in Teva Pharmaceutical Industries Limited in Q2 2015 and held it in 6 quarters.
Patten Group's Teva Pharmaceutical Industries Limited position peaked at $44.3K in Q3 2016.
739 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2016.

Based on Patten Group's 13F filing for Q4 2016, filed 10 Feb 2017.